Sunday, July 25, 2010

Genzyme + ???

So there’s no doubt now that Genzyme (Ticker: GENZ) is in play. First there was the Sanofi-Aventis (Ticker: SNY) news last Friday and now there are reports that Glaxo SmithKline (Ticker: GSK) is eyeing Genzyme. Analysts have also speculated that Johnson & Johnson (Ticker: JNJ) may get into the mix. I originally thought that Genzyme would get taken out at ~ $70 to $80 by Sanofi-Aventis, but with other bidders emerging, the price just went up. I would not be surprised if Genzyme gets sold for $90 plus... It’s going to be interesting to see how this plays out. I’m holding tight to my Genzyme shares...


Post a Comment

<< Home